CTXR Citius Pharmaceuticals Inc.

Citius Pharmaceuticals Inc is a specialty pharmaceutical company engaged in development and commercialization of therapeutic products for markets using patented or proprietary formulations and modified drug delivery technology.

$0.89
As of 07/01/2022     IEX book   CBOE book

---

Security Information

---

Category1:  US Equity
Category2:  Common stocks
Category3:  Micro cap
GICS sector:  Health Care
Industry:  Biotechnology
Index country:  USA
Country of incorporation:  USA
IPO date:  10/02/2014
Outstanding shares:  146,129,630
Average volume:  1,620,697
Market cap:   $134,439,260
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
Sedol:      BF2BFF5

---

Valuation   (See tab for details)

---

PE ratio:   0.00
PB ratio:   1.11
PS ratio:   0.00
Return on equity:   -6,429,727.18%
Net income %:   0.00%